TY - JOUR AU - Abhijit Chakraborty AU - Upasana Roy AU - Abhishek Shankar AU - Aalekhya Biswas AU - Faisal Aziz PY - 2020/08/24 Y2 - 2024/03/28 TI - Cancer Immunotherapy and COVID-19: Mind the Gap JF - Asian Pacific Journal of Cancer Care JA - apjcc VL - 5 IS - S1 SE - Short Communication DO - 10.31557/apjcc.2020.5.S1.213-218 UR - http://waocp.com/journal/index.php/apjcc/article/view/508 AB - The urgent need to develop a vaccine to prevent SARS-CoV-2 pandemic is now the main focus all over the world. Over the past decade, scientists and drug industries have been works on different kinds of human threatening disease like H1N1 influenza, Ebola, Zika, SARS-CoV, MERS, etc. The knowledge to work in this area, helping the researcher a lot to develop a vaccine in at Pandemic Speed. However, the development of a new drug and starting application on human heal is a time-consuming manner. It becomes very hard in the case of COVID-19 as the virus characters changing rapidly. Here we discuss whether the anti-cancer immunotherapy could give some hope to protect against COVID-19 and also enrollment of cancer vaccine which started a randomized clinical trial to boost the treatment strategies against COVID-19 on an emergency basis. ER -